Nashik-Maharashtra, India

Tejas Gunjikar

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 33(Granted Patents)


Location History:

  • Nashik, IN (2017 - 2018)
  • Nashik-Maharashtra, IN (2015 - 2019)

Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Tejas Gunjikar: Innovator in Pharmaceutical Composition

Introduction

Tejas Gunjikar is a prominent inventor based in Nashik, Maharashtra, India. He has made significant contributions to the field of pharmaceuticals, particularly in developing fast-dissolving compositions that enhance drug delivery. With a total of 6 patents to his name, Gunjikar is recognized for his innovative approaches to pharmaceutical formulations.

Latest Patents

Among his latest patents, Gunjikar has developed a fast-dissolving pharmaceutical composition. This invention is directed towards a pharmaceutical composition that comprises an open matrix network carrying a pharmaceutically active ingredient, wherein the open matrix network includes inulin. This innovative approach aims to improve the efficacy and absorption of medications, making them more accessible to patients.

Career Highlights

Tejas Gunjikar currently works at Ferring B.V., a global leader in the pharmaceutical industry. His role involves research and development, where he focuses on creating advanced pharmaceutical solutions. His expertise in formulating fast-dissolving compositions has positioned him as a key player in the field.

Collaborations

Gunjikar collaborates with talented professionals in his field, including Varinder Ahuja and Kristin Wannerberger. These collaborations enhance the innovative processes within his projects and contribute to the success of their pharmaceutical developments.

Conclusion

Tejas Gunjikar is a notable inventor whose work in fast-dissolving pharmaceutical compositions has the potential to transform drug delivery systems. His contributions to the field are significant, and his ongoing research continues to pave the way for advancements in pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…